Root Financial Partners’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$440 Buy
+61
New +$531 ﹤0.01% 3266
2026
Q2
– Sell
-14
Closed -$86 – 2577
2026
Q1
$86 Buy
+14
New +$100 ﹤0.01% 3306

Other funds holding RNAC

Root Financial Partners's RNAC Position: Q3 2026 in Review

Root Financial Partners opened a new position in Cartesian Therapeutics (RNAC) in Q3 2026: 61 shares worth $440. The stake represents ﹤0.01% of the portfolio and ranks #3266 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in RNAC as recently as Q1 2026.

Root Financial Partners first reported a position in RNAC in Q1 2026 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold RNAC as of Q3 2026.

  • Root Financial Partners held 61 shares of Cartesian Therapeutics worth $440 as of Q3 2026.
  • Cartesian Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3266 holding.
  • Root Financial Partners first reported a position in Cartesian Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.